Piramal Pharma's Turbhe Facility Tagged 'Voluntary Action Indicated' By US FDA

Piramal Pharma Ltd. on Monday said the US Food and Drug Administration has classified its manufacturing facility in Turbhe, Navi Mumbai, as "voluntary action indicated" in the establishment inspection report.

The US FDA had inspected the facility between February 11 and February17, the company said in an exchange filing.